Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma
Authors:
- H. DralleHDH. Dralle
- C. EngCEC. Eng
- F. RaueFRF. Raue
- C.E. BroelschCBC.E. Broelsch
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTCNature Genetics, 1994
- A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinomaNature, 1994
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHuman Molecular Genetics, 1993
- Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature, 1993
- Presymptomatic screening for multiple endocrine neoplasia type 2A with linked DNA markersThe Lancet, 1991
- Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2AGenomics, 1990
- The Clinical Outcome of Prospective Screening for Multiple Endocrine Neoplasia Type 2ANew England Journal of Medicine, 1988
- RISK ESTIMATION AND SCREENING IN FAMILIES OF PATIENTS WITH MEDULLARY THYROID CARCINOMAThe Lancet, 1988
- Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkageNature, 1987
- A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10Nature, 1987